Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7160-7167
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7160
Table 4 Proportion of cholangiocarcinoma patients who had underlying diabetes and chronic liver diseases n (%)
Total(n = 39421)Northeast(n = 24237)North(n = 6696)PNorthvsNortheastCentral(n = 5294)PcentralvsNortheastBangkok(n = 1113)PBangkokvsNortheastSouth(n = 1055)PSouthvsNortheastPfor all regions
Diabetes4502 (11.42)2803 (11.56)572 (8.54)< 0.0001689 (13.01)0.11389 (18.36)< 0.0001133 (12.60)0.25< 0.0001
Cirrhosis1896 (4.81)963 (3.97)440 (5.39)< 0.0001362 (6.84)< 0.000183 (7.46)< 0.000163 (5.97)< 0.0001< 0.0001
Chronic hepatitis B291 (0.74)106 (0.44)91 (1.36)< 0.000159 (1.11)< 0.000118 (1.62)0.0512 (1.52)0.002< 0.0001
Chronic hepatitis C196 (0.50)92 (0.38)57 (0.85)< 0.000120 (0.38)0.3317 (1.53)0.123 (0.28)< 0.001< 0.0001